| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pediatrics, Division of Pediatric Endocrinology, University of Michigan Ann Arbor, Michigan 48109
Address requests for reprints to: Dr. Padmanabhan, D 3252 Medical Professional Building, Department of Pediatrics, University of Michigan Hospitals, Ann Arbor, Michigan 48109-0781.
To determine the influence of estrogenic steroids on serum FSH bioactivity (B) and immunoreactivity (I) and the FSH isoform distribution profiles, we studied normal women during ovulatory menstrual cycles and a patient with gonadal dysgenesis treated with diethylstilbestrol (DES). Four women with ovulatory menstrual cycles, as judged from their serum immunoreactive LH, FSH, progesterone, and estradiol profiles in daily blood samples, had a significant increase in the mean FSH B/I ratio (P < 0.05) during the midcycle phase of their menstrual cycles. Similarly, in the patient with gonadal dysgenesis the FSH B/I ratio rose significantly (P < 0.05) after 3 weeks of DES treatment and declined during the posttreatment period. In five additional normal women, serum obtained during the follicular, midcycle, and luteal phases of their menstrual cycles was chromatofocused, and the FSH isoform distribution pattern determined. Sera obtained from the patient with gonadal dysgenesis before, during, and after DES administration were pooled and studied similarly. Chromatofocusing of a human pituitary tumor extract allowed for determination of the FSH B/I ratio in different pH ranges. The highest FSH B/I ratio was found in the more basic fractions (pH range 5.6–6.0) compared to the acidic fractions. During both the midcycle phase of the normal cycles and the DES administration period in the studies of the patient with gonadal dysgenesis, there was a shift of the FSH isoforms (as measured by immunoassay) to the basic pH range. In contrast, the mid- to late luteal phase samples, which had low B/I ratios, had an increase in FSH isoforms in the acidic pH range (<4.8). Similarly, in the patient with gonadal dysgenesis FSH isoforms in the basic range were more abundant during the DES treatment period than in the pre- or posttreatment serum pools. Therefore, it appears that endogenous and exogenous estrogenic stimulation alters FSH isoform distribution such that FSH isoforms that are more basic and have increased biological activity are secreted.
* Presented in part at the American Physiological Society Meeting, New Orleans, LA, 1986, and the 69th Annual Meeting of The Endocrine Society, Indianapolis, IN, 1987. This work was supported by NIH Grant HD-18515 and biomedical support grants (to V.P. and I.Z.B).
Received February 5, 1988.
This article has been cited by other articles:
![]() |
T. L. Steckler, J. S. Lee, W. Ye, E. K. Inskeep, and V. Padmanabhan Developmental Programming: Exogenous Gonadotropin Treatment Rescues Ovulatory Function But Does Not Completely Normalize Ovarian Function in Sheep Treated Prenatally with Testosterone Biol Reprod, October 1, 2008; 79(4): 686 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wide, T. Naessen, I. Sundstrom-Poromaa, and K. Eriksson Sulfonation and Sialylation of Gonadotropins in Women during the Menstrual Cycle, after Menopause, and with Polycystic Ovarian Syndrome and in Men J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4410 - 4417. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization Endocr. Rev., April 1, 2006; 27(2): 170 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.V. Velasquez, S. Creus, R.V. Trigo, S.B. Cigorraga, E.H. Pellizzari, H.B. Croxatto, and S. Campo Pituitary-ovarian axis during lactational amenorrhoea. II. Longitudinal assessment of serum FSH polymorphism before and after recovery of menstrual cycles Hum. Reprod., April 1, 2006; 21(4): 916 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ulloa-Aguirre, C. Timossi, J. Barrios-de-Tomasi, A. Maldonado, and P. Nayudu Impact of Carbohydrate Heterogeneity in Function of Follicle-Stimulating Hormone: Studies Derived from in Vitro and in Vivo Models Biol Reprod, August 1, 2003; 69(2): 379 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Perlman, B. van den Hazel, J. Christiansen, S. Gram-Nielsen, C. B. Jeppesen, K. V. Andersen, T. Halkier, S. Okkels, and H. T. Schambye Glycosylation of an N-Terminal Extension Prolongs the Half-Life and Increases the in Vivo Activity of Follicle Stimulating Hormone J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3227 - 3235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Golub, C. E. Hogrefe, S. L. Germann, B. L. Lasley, K. Natarajan, and A. F. Tarantal Effects of Exogenous Estrogenic Agents on Pubertal Growth and Reproductive System Maturation in Female Rhesus Monkeys Toxicol. Sci., July 1, 2003; 74(1): 103 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. West, N. E. Carlson, J. S. Lee, A. S. McNeilly, T. P. Sharma, W. Ye, and V. Padmanabhan Acidic Mix of FSH Isoforms Are Better Facilitators of Ovarian Follicular Maturation and E2 Production than the Less Acidic Endocrinology, January 1, 2002; 143(1): 107 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Zarinan, A. Olivares, D. Soderlund, J.P. Mendez, and A. Ulloa-Aguirre Changes in the biological:immunological ratio of basal and GnRH-releasable FSH during the follicular, pre-ovulatory and luteal phases of the human menstrual cycle Hum. Reprod., August 1, 2001; 16(8): 1611 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ulloa-Aguirre, C. Timossi, and J.P. Mendez Is there any physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: I. Gondatrophins are synthesized and released in multiple molecular forms. A matter of fact Hum. Reprod., April 1, 2001; 16(4): 599 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.Y. Andersen, L. Leonardsen, A. Ulloa-Aguirre, J. Barrios-De-Tomasi, K.S. Kristensen, and A.G. Byskov Effect of different FSH isoforms on cyclic-AMP production by mouse cumulus-oocyte-complexes: a time course study Mol. Hum. Reprod., February 1, 2001; 7(2): 129 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Horsman, J.A. Talbot, J.D. McLoughlin, A. Lambert, and W.R. Robertson A biological, immunological and physico-chemical comparison of the current clinical batches of the recombinant FSH preparations Gonal-F and Puregon Hum. Reprod., September 1, 2000; 15(9): 1898 - 1902. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Andersen, L. Leonardsen, A. Ulloa-Aguirre, J. Barrios-De-Tomasi, L. Moore, and A.G. Byskov FSH-induced resumption of meiosis in mouse oocytes: effect of different isoforms Mol. Hum. Reprod., August 1, 1999; 5(8): 726 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Raga, F. Bonilla-Musoles, E.M. Casan, and F. Bonilla Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome Hum. Reprod., June 1, 1999; 14(6): 1431 - 1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D'Antonio, F. Borrelli, A. Datola, R. Bucci, M. Mascia, P. Polletta, D. Piscitelli, and R. Papoian Biological characterization of recombinant human follicle stimulating hormone isoforms Hum. Reprod., May 1, 1999; 14(5): 1160 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. J. M. Fauser and A. M. van Heusden Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences Endocr. Rev., February 1, 1997; 18(1): 71 - 106. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |